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ABSTRACT
A reversed-phase liquid chromatography with ultraviolet detection is described for the determination of cotinine. A mobile
phase consisted of an acetate buffer with sodium octanesulfonate as an ion pair reagent and methanol was used to resolve cotinine from theobromine, theophylline, arecoline and nicotine. Using an octadecyl-type column, a good separation was achieved in
12 min. The wavelength of UV detector was set at 260 nm. With p-nitroaniline as internal standard, human urine samples were
cleaned up by liquid-liquid extraction. The regression equations obtained from both the standard and the biological samples were
linear between 0.1 - 10.0 μg/mL (r > 0.999). The detection limit for cotinine is 30.0 ng/mL. The R.S.D. and R.E. of intraday and
interday are less than 3.93% and 3.07%, respectively (n = 6). The recoveries are all greater than 96.44%. This method has been
successfully applied to the determination of urinary cotinine content in several heavy smokers.
Key words: cotinine, HPLC, human urine

INTRODUCTION
The tobacco is one of the most commonly used
recreational substance in the world (1). Cigarette smoking
increases the risk of malignant lung cancers, heart and
other lung diseases (2-7). In 1999 the epidemiologists
of World Health Organization (WHO) predicted that
approximately 8.4 million people would be killed annually due to their tobacco usage by late 2020s (8).
Cotinine is a major metabolite of nicotine found
in the urine of smokers(9). Cotinine is used to evaluate secondhand exposure to environmental tobacco
smoke (10) and to validate smoking abstinence (11). It had
been proposed that genetic polymorphisms in nicotine metabolism may serve as a major determinant of an
individual’s health risk to smoking and their addicting
behavior. Hepatic cytochrome P4502A6 (CYP2A6)
isozymes are responsible for catalyzing the major route
of nicotine metabolism as well as C-oxidation of cotinine,
followed by hydroxylation to trans-3’-hydroxycotinine (12).
Recently, the trans-3’- hydroxycotinine/cotinine ratio has
been suggested as an useful index for determination of the
rate of nicotine metabolism, and as a mean to assess this
CYP2A6 biomarker activity(13).
* Author for correspondence. Tel: +886-7-3121101ext 2647;
Fax: +886-7-3210683; E-mail: m715009@kmu.edu.tw

The most frequently used analytical methods for the
determination of cotinine levels are high-performance
liquid chromatography (HPLC)(14-17) and gas chromatography(18-20). Other techniques such as capillary electrophoresis (21) and enzyme-linked immunosorbent assay(22)
have also been described. HPLC with ultraviolet (UV)
detection is the most widely used analytical method,
because it is more simple, economical, and widely available than other techniques.
We are interested in developing a simple analytical
method for determination of urinary cotinine levels
because it can be easily adopted as a practical tool for
assessing health risks of both smokers and secondhand
smokers in Taiwan. Furthermore, this method can also be
used to simultaneously determine cotinine and trans-3’hydroxycotinine levels in urine and serves as an useful
tool for the assessment of the trans-3’-hydroxylcotinine/
cotinine ratio.
According to a previously published procedure, it
was not easy to achieve a complete resolution of cotinine from caffeine by HPLC within a short period of
10 min(23). Caffeine is an ingredient in tea, coffee and
many over-the counter medicines. In addition, many
people also have a habit of chewing betel nuts in Taiwan.
Therefore, an analytical method which can separate those
active ingredients of betel nut, tea and coffee, such as
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arecoline, theobromine, theophylline and caffeine, will
be a useful tool to determine urinary cotinine for these
people in Taiwan.
In the present study, we describe a simple HPLC
method using an octadecyl-type column coupled with UV
detection for determination of cotinine in human urine
with liquid-liquid extraction. This method can easily
resolve cotinine from theobromine, theophylline, caffeine,
arecoline and nicotine in a short period of 12 min.
The method has also been successfully applied to determine urinary cotinine from several smokers.

MATERIALS AND METHODS
I. Reagents and Standards

analysis. p-Nitroaniline solutions were diluted with 30%
methanolic aqueous solution to 1 μg/mL as internal standard for biological analysis.
IV. Extraction Method
Urine samples were obtained from test individuals
by collecting the first urine in the morning and were
kept frozen at -20°C until assay. Each of 500 μL urine
samples was added with internal standard solution
(1 μg/mL). After the addition of 100 μL 10 N potassium
hydroxide and 2 mL dichloromethane/n-butanol solution (9: 1, v/v), the urine sample was shaken for 10 min
at ambient temperature. One milliliter of inferior organic
phase was evaporated to residue and was re-dissolved in
250 μL water/methanol (70: 30, v/v) solution and 20 μL
was injected into HPLC for analysis.

All reagents used were of analytical grade and the
organic solvents were of HPLC grade. Cotinine and (S)-()-Nicotine were purchased from Lancaster (UK). Arecoline hydrobromide was purchased from MP Biomedicals Inc. (Eschwege, Germany). p-Nitroaniline (internal
standard; I.S.) was obtained from Merck (Darmstadt,
Germany). Water, used for the preparation of mobile phase
and related aqueous solution, was purified by Milli-Q
from Millipore (Billerica, MA USA). Methanol (MeOH)
and triethylamine (TEA) were from Tedia (Fairfield, OH
USA). Caffeine, sodium 1-octanesulfonate, theobromine
and theophylline were from TCI (Tokyo, Japan).

V. Precision and Accuracy

II. Apparatus and Chromatographic Conditions

The recovery for cotinine in human urine analysis was calculated at three concentrations (0.5 μg/mL,
5.0 μg/mL, 10.0 μg/mL). The absolute recovery of cotinine was determined by the peak area ratio of urine
sample to standard solution and the relative recovery was
calculated at three different concentrations (0.5 μg/mL,
5.0 μg/mL, 10.0 μg/mL) based on daily standard curve.

The HPLC analysis was carried out on an Agilent
series 1100 LC system, (Foster City, CA USA) equipped
with Soma S-3702 UV-Vis detector and DataApex
ClarityTM software for LC system.
Analysis was performed on an Astec octadecyl-type
(250 × 4.6 mm, 5 μm) column at ambient temperature.
Mobile phase consisted of an acetate buffer (containing
30.0 mM sodium acetate, 100 mM acetic acid and
10.0 mM sodium octanesulfonate as ion pair reagent) and
methanol (70: 30, v/v). The flow rate was 1.0 mL/min.
Injection volume was 20 μL. The eluate was monitored
by absorbance at 260 nm.
III. Preparation of Stock and Working Solutions
Stock solutions of cotinine were prepared at 1 mg/mL
in 30% methanolic aqueous solution for human urine analysis. p-Nitroaniline was prepared at 0.2 mg/mL in 30%
methanolic aqueous solution. Solutions were kept at 4°C.
Working solutions of cotinine were diluted from
stock solutions with 30% methanolic aqueous solution
to 0.5 µg/mL, 1.0 μg/mL, 2.0 μg/mL, 5.0 μg/mL and
10.0 μg/mL for calibration curve and to 0.8 μg/mL,
4.0 μg/mL and 8.0 μg/mL, as QC samples used for urine

For standard analysis, the intraday and interday assays
in precision and accuracy were performed with six replicates for each of low (0.79 μg/mL), middle (3.98 μg/mL)
and high (7.96 μg/mL) quality control samples. For biological analysis, the intraday and interday assays in precision
and accuracy were run with six replicates for each of low
(0.80 μg/mL), middle (4.00 μg/mL) and high (8.00 μg/mL)
quality control samples.
VI. Recovery

VII. Stability
Stability of cotinine in working solutions and in
urine samples (previously stored in -20°C) at room
temperature were determined by the solutions and
samples stayed at room temperature for 72 hours.
Furthermore, stability of cotinine in urine samples at
room temperature was determined by the samples stayed
at room temperature for 120 hours. Stability of cotinine
in spiked urine samples through freeze-thaw procedure was tested at low (2.0 μg/mL) and high (8.0 μg/mL)
concentrations after three freeze-thaw cycles.
VIII. Selectivity
A 30% methanolic aqueous solution containing
seven different chemicals (i.e. theobromine, theophylline,
cotinine, caffeine, arecoline, p-nitroaniline and nicotine)
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was used to validate the selectivity of the developed
analytical method.
XI. Application
The samples of the first urine in the morning of six
smokers were separately collected for 5 consecutive days
and the urinary cotinine levels were determined. Three
of these smokers have agreed to undergo another 5 days
cycle and the urinary cotinine contents were analyzed for
comparative purpose. The levels of cotinine were determined based on the daily standard curve.

RESULTS AND DISCUSSION
I. High Performance Liquid Chromatography
The chromatograms of the extracts of urine blank
and urine blank spiked with cotinine and p-nitroaniline
are shown in Figure 1. The retention times of cotinine
and p-nitroaniline are 6.5 and 10.9 min, respectively. An
acceptable separation for cotinine and caffeine (r.t. 7.3 min)
is achieved in a period of 8 min, which is faster than the
method of Baranowski et al.(23), and no interference from
caffeine and p-nitroaniline with cotinine was observed.
II. Linearity and Limit of Quantitation
In standard analysis based on six replicates, regression equations of intraday and interday analysis are Y =
(1.1096 ± 0.0210) X + (0.0085 ± 0.0336) and Y = (1.1099 ±
0.0212) X + (-0.0027 ± 0.0243), respectively. The correlation coefficient of regression equation of intraday analysis is 1.00 as the same as that of analysis interday equation. The limit of quantitation (LOQ) was determined to
be 100 ng/mL (S/N = 10, injection 20 μL).

In human urine analysis based on six replicate
analyses, regression equations of intraday and interday
analysis are Y = (1.0118 ± 0.0064) X + (0.0630 ± 0.0071)
and Y = (1.0075 ± 0.0140) X + (0.0662 ± 0.0221), respectively. Both correlation coefficients of regression equations are over 0.999. The LOQ was also determined to be
100 ng/mL (S/N = 10, injection 20 μL).
III. Accuracy and Precision
In standard analysis, the relative standard deviation
(R.S.D.) and relative error (R.E.) of intraday and interday
analysis were below 2.20% and 1.63% respectively
(n = 6). In biological analysis, the R.S.D. and R.E. of
intraday and interday were below 3.57% and 3.70%
respectively (n = 6) (Table 1).
IV. Recovery
The recovery of cotinine from urine sample was
measured under the extraction procedures as described
above. The absolute recovery for a cotinine-spiked
human urine samples was in the range of 96.44-97.42%.
The relative recovery for cotinine spiked in human urine
ranges from 97.06 to 100.67% (Table 2). The recovery
from urine sample of this method by using a simple
liquid-liquid extraction is better than the method of
Doctor (15), which the average recovery from urine sample
was 88% for cotinine by a solid-phase extraction method.
V. Stability
The stability of cotinine in water/methanol (70/30,
v/v) solution was assessed by re-analyzing samples which
were left in the autosampler at room temperature for
72 hours. Analyte concentration is stable in standard at

3.0
2.5
2.0
1.5
1.0
0.5

Concentration
measured (μg/mL)a

R.S.D.
(%)

R.E.
(%)

0.8

0.82 ± 0.02

3.57

3.02

4.0

3.91 ± 0.11

2.89

-2.03

7.70 ± 0.10

1.31

-3.70

0.8

0.82 ± 0.02

2.85

3.06

4.0

4.03 ± 0.15

3.39

0.77

8.0

7.83 ± 0.21

2.78

-2.02

Intraday analysisb
4

6

3.5
3.0
2.5
2.0
1.5

6.513 1

a.

2

8

10

Retention time (min)

4

6

b.

c.

8

10

12

8.0

10.927 3

2

Response (mv)

Concentration
known (μg/mL)

b.

7.280 2

Response (mv)

Table 1. Precision and accuracy for the determination of cotinine
spiked in human urine

c

Interday analysis

12

Retention time (min)

Figure 1. The chromatograms of cotinine and p-nitroaniline. (A) The
chromatogram of urine blank, (B) The chromatogram of urine blank
spiked with cotinine and p-nitroaniline. Peaks: a. cotinine 2 μg/mL
(11.3 μM), b. caffeine, c. p-nitroaniline (I.S.) 1 μg/mL (7.2 μM).

a

Mean ± S.D. of six replicate analyses.
Intraday data was based on six replicate analyses.
c
Interday data was based on six replicate analyses on six different days.
b
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VI. Selectivity
In Taiwan, people are commonly drinking a lot of
caffeinated beverages, teas and chewing betel nuts. The
method was designed to determine the urinary cotinine
contents of these people. Selectivity of cotinine among
those substances, such as caffeine, theobromine, theophylline and arecoline must be met in this method. Figure
2 clearly demonstrated a good separation of cotinine
peak with no interference from theobromine, theophylline, caffeine, arecoline and nicotine in the chromatogram of a short period of time (13.5 min). In previous
studies(14-17,23), theobromine, theophylline, caffeine,
arecoline and nicotine were not included to examine the
selectivity of HPLC method for cotinine. With this selectivity, the method will be feasibly applied in Taiwan and
other Southeast Asian countries.

shown in Table 4. These smokers are classified as
moderate smokers with urinary cotinine concentrations at 500-2500 ng/mL according to the literature (24),
which defined urinary cotinine concentrations (ng/mL)
at 150-500 as a light smoker, 500-2500 as a moderate
smoker, and above 2500 as a heavy smoker. Without
changing their life styles and habits, urine samples of
three of six voluntary male smokers were analyzed once
again for another 5-day period. The results indicated
that mean cotinine concentrations of the urine samples
taken from the same individual between the two test run
differed within a small range of 47-100 ng/mL (Table 4).

CONCLUSIONS
A method using HPLC with UV detector for the

3.0

f.

2.0

b.

a.

e.
g.

1.5
1.0
0.5
0.0
2

4

6

VII. Application

8

10

12

Retention time (min)

Recovery
(%)a

0.5

0.48 ± 0.01

97.06

5.0

4.90 ± 0.05

98.18

10.0

10.06 ± 0.10

100.67

Mean ± S.D. of five replicate analyses.

3.0
2.5

b.

c.

10.233 3

Concentration
measured (μg/mL)

a.

3.5

6.350 1

Concentration
spiked (μg/mL)

4.0

6.990 2

Table 2. Relative recovery of cotinine in human urine

Figure 2. The chromatogram of some chemicals. Peaks: a. theobromine, b. theophylline, c. cotinine, d. caffeine, e. arecoline, f.
p-nitroaniline, g. nicotine.

Response (mv)

This method was applied for the determination of
cotinine concentrations in urine of six male smokers
for five consecutive days (Figure 3). The results are

a

d.

c.

2.5

Response (mv)

room temperature for 72 hours. The stability of cotinine
in human urine at room temperature was also estimated
by urine sample of cotinine stored in a room at ambient
temperature for 120 hours. No degradation was observed
in the analytic samples until 120 hours.
The results of stability determination of the urinary
cotinine at low (2.0 μg/mL) and high (8.0 μg/mL) concentrations after three freeze-thaw cycles are listed in Table
3. No degradation was observed in neither of the two
concentrations studies.

2.0
1.5
2

4

6

8

10

Retention time (min)

Figure 3. The Chromatogram of a smoker’s urine. Peaks: a. cotinine,
b. caffeine, c. p-nitroaniline.

Table 3. The stability of urinary cotinine in three freeze-thaw cycles

a

Sample (μg/mL)

N

2. 0
8.0

Cycle 1

Cycle 2

Cycle 3

Measureda (μg/mL)

R.E.(%)

Measureda (μg/mL)

R.E. (%)

Measureda (μg/mL)

R.E. (%)

3

2.05 ± 0.01

2.95

2.09 ± 0.01

4.85

2.08 ± 0.02

4.10

3

8.38 ± 0.08

4.80

8.28 ± 0.07

3.57

8.34 ± 0.09

4.28

Mean ± S.D. of triplicate analyses.
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Table 4. Assay results for smokers’ urine
Smoker’s number

Cotinine concentration (ng/mL)
Day 1

Day 2

Day 3

Day 4

Day 5

847

857

719

551

630

720 ± 133

1546

1805

1389

1455

1341

1507 ± 183

2201

1854

836

848

1296

1407 ± 608#

1011

1414

1421

1833

1786

1493 ± 333

1812

2570

2491

2631

1823

2265 ± 411

2630

1879

2504

2602

1945

2312 ± 368#

1160

1822

1225

903

1077

1237 ± 348

2087

1947

1943

1689

1617

1856 ± 196

1867

1770

1333

1667

2163

1760 ± 302#

1
2
2

#

3
4
4

#

5
6
6

#

Mean ± SD

#: The results of second test run.

analysis of cotinine with good selectivity has been developed. The method is simple, precise and accurate with a
sample prepared by liquid-liquid extraction. Because the
method can well separate cotinine from theobromine,
theophylline, caffeine, arecoline and nicotine, it will be
suitable for determining urinary cotinine levels of the
smokers and second-hand smokers in Taiwan and other
Southeast Asian countries. The method has been successfully applied to determine the urinary cotinine concentrations of six smokers.
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